News

News

JPEO-CBRND Awards $39.8 Million Contract to Kaléo, Inc. for Next Generation Reconstitution Autoinjector Device – Atropine (RAD-A)
July 18, 2023
Service member kneels in the snow and reaches for small medical device that is a loaded autoinjector

Air Force fields Joint Service Aircrew Mask for Strategic Aircraft
July 5, 2023
Two men stand in the foreground. On the left, an Airmen demonstrates how to wear the Joint Service Aircrew Mask for Strategic Aircraft (JSAM-SA) and the trainer stands in civilian clothes on right during an instructional briefing.

JPEO-CBRND Showcases Critical Capabilities at APG Demonstration Days 2023
June 23, 2023
Three boys stand and one holds a controller for a semi-autonomous vehicle.

JPEO-CBRND supports biennial exercise of the Joint Biological Agent Decontamination System
June 12, 2023
A group stands in front of the JBADS and a C-130 Hercules for a posed photo

Joint Program Executive Office for Chemical, Biological, Radiological and Nuclear Defense Pilots New Approach in Connecting with Innovators
May 26, 2023
Mr. Darryl Colvin, JPEO-CBRND, speaks to an audience as he stands next to a mannequin wearing the UIPE-FOS CBRN protective gear.

JPEO-CBRND Hosts CVCAD Exercise at Soldier Integration Facility
May 26, 2023
one woman wearing a hijab and one man wearing a hat work to equip a mannequin with man-portable CBRN sensors gear.

Pacific Air Forces Airmen Test Next Generation Aircrew Protection Equipment
May 24, 2023
Airmen stands in hangar wearing CBRND pilot gear

Capacity Expansion Team Bolsters Nation’s Vaccine Industrial Base in Response to COVID-19
April 27, 2023
Crystal Tyler, pharmacy technician, prepares an injection for an Operation Warp Speed patient volunteer at Brooke Army Medical Center, Fort Sam Houston, Texas, November 16, 2020. BAMC and Wilford Hall Ambulatory Surgical Center are participating in the Phase III trial to evaluate the vaccine under development by AstraZeneca as part of a national initiative to accelerate the development, production and distribution of COVID-19 vaccines, therapeutics and diagnostics.

Lawyers and Pandemic Response: How the Joint Assisted Acquisition (JA2) Legal Cell Joined the Fight Against COVID-19
April 18, 2023
Ten people in business attire stand in front of flags and hold certificates of appreciation and award for service.

AL&T Feature - "Sensor Suite - Upgraded"
April 1, 2023
Yellow star with black background


JPEO-CBRND Press Kit

Download our press kit, which includes helpful documents to better understand our work, such as – Command Brief, Chemical Biological Defense Program's Enterprise strategy, the JPEO-CBRND's Capabilities Catalog, Leadership Biographies, COVID-19 fact sheets, and contracting overview documents.  

 

 


JPEO-CBRND Public Affairs Office

The JPEO-CBRND Public Affairs Office coordinates and responds to all public affairs and media relations needs on behalf of the JPEO-CBRND. To request a speaker, subject matter expert, or for other interview or request for comment please email our Public Affairs Office email below.   

 

The information contained in these articles has been reviewed and approved for public release. 
 
The appearance of hyperlinks does not constitute endorsement by the JPEO-CBRND of non-U.S. government sites or the information, products, or services contained therein. Although the JPEO-CBRND may or may not use these sites as additional distribution channels for Department of Defense information, it does not exercise editorial control over all the information that you may find at these locations. Such hyperlinks are provided consistent with the stated purpose of this website.